BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21176309)

  • 1. Postpartum hemorrhage in a Jehovah's Witness patient controlled with Tisseel, tranexamic acid, and recombinant factor VIIa.
    Arab TS; Al-Wazzan AB; Maslow K
    J Obstet Gynaecol Can; 2010 Oct; 32(10):984-7. PubMed ID: 21176309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy-associated breast cancer: a review for the obstetrical care provider.
    Somerset D
    J Obstet Gynaecol Can; 2011 Sep; 33(9):897-898. PubMed ID: 21923985
    [No Abstract]   [Full Text] [Related]  

  • 3. [Obstetric Surgery with High Risk of Postpartum Hemorrhage in a Jehovah's Witness].
    Carp M; Maurício S; Lança F
    Acta Med Port; 2021 Mar; 34(4):300-303. PubMed ID: 34214421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant factor VIIa for major obstetric haemorrhage in a Jehovah's Witness.
    Laird R; Carabine U
    Int J Obstet Anesth; 2008 Apr; 17(2):193-4. PubMed ID: 18308545
    [No Abstract]   [Full Text] [Related]  

  • 5. Preferences of Jehovah's Witnesses regarding haematological supports in an obstetric setting: experience of a single university teaching hospital.
    Husarova V; Donnelly G; Doolan A; Garstka M; Ni Ainle F; McCaul C
    Int J Obstet Anesth; 2016 Feb; 25():53-7. PubMed ID: 26597403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemostatic resuscitation in postpartum hemorrhage - a supplement to surgery.
    Ekelund K; Hanke G; Stensballe J; Wikkelsøe A; Albrechtsen CK; Afshari A
    Acta Obstet Gynecol Scand; 2015 Jul; 94(7):680-692. PubMed ID: 25660118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven).
    Tanaka KA; Waly AA; Cooper WA; Levy JH
    Anesthesiology; 2003 Jun; 98(6):1513-5. PubMed ID: 12766668
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of Labour and Delivery in a Patient With Acquired Factor VII Deficiency With Inhibitor: A Case Report.
    Matei A; Dolan S; Andrews J; Rivard GÉ
    J Obstet Gynaecol Can; 2016 Feb; 38(2):160-3. PubMed ID: 27032741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of intestinal hemorrhage in a Jehovah's Witness patient.
    Veneri D; Franchini M
    Am J Hematol; 2005 Aug; 79(4):344-5. PubMed ID: 16044447
    [No Abstract]   [Full Text] [Related]  

  • 10. Major obstetric hemorrhage.
    Le Gouez A; Mercier FJ
    Transfus Clin Biol; 2016 Nov; 23(4):229-232. PubMed ID: 27592155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of anaemia in the polytrauma Jehovah's Witness.
    Murphy DP; O'Donnell T; McDonnell J; McElwain JP
    Ir Med J; 2003 Jan; 96(1):8-10. PubMed ID: 12617434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aortic dissection and hypothermic arrest in a Jehovah's Witness patient: a case for recombinant factor VIIa?
    Ballen J; Raabe M; Muirhead B
    Can J Anaesth; 2006 Apr; 53(4):353-6. PubMed ID: 16575032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of clotting factors and other prohemostatic drugs for obstetric hemorrhage.
    Mercier FJ; Bonnet MP
    Curr Opin Anaesthesiol; 2010 Jun; 23(3):310-6. PubMed ID: 20216063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using recombinant activated factor VII, B-Lynch compression, and reversible embolization of the uterine arteries for treatment of severe conservatively intractable postpartum hemorrhage: new method for management of massive hemorrhage in cases of placenta increta.
    Mechsner S; Baessler K; Brunne B; Albrecht T; Hopp H; Dudenhausen JW
    Fertil Steril; 2008 Nov; 90(5):2012.e1-5. PubMed ID: 18462726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing postburn injury anemia in a Jehovah's Witness patient.
    Barsun A; Sen S; Palmieri TL; Greenhalgh DG
    J Burn Care Res; 2014; 35(4):e258-61. PubMed ID: 24121804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenic embolization in a Jehovah's Witness: role of recombinant human factor VIIa.
    Mindikoglu AL; Anantharaju A; George M; Leone N; Bejna J; Van Thiel DH
    Hepatogastroenterology; 2003; 50(53):1697-9. PubMed ID: 14571820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of recombinant factor viia in a jehovah's witness with auto-immune thrombocytopenia and post-splenectomy haemorrhage.
    Waddington DP; McAuley FT; Hanley JP; Summerfield GP
    Br J Haematol; 2002 Oct; 119(1):286-8. PubMed ID: 12358947
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of pregnancy in a Jehovah's Witness.
    Gyamfi C; Berkowitz RL
    Obstet Gynecol Clin North Am; 2007 Sep; 34(3):357-65, ix. PubMed ID: 17921004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe gastrointestinal haemorrhage responding to recombinant factor VIIa in a Jehovah's Witness with refractory immune thrombocytopenia.
    Virchis A; Hughes C; Berney S
    Hematol J; 2004; 5(3):281-2. PubMed ID: 15167918
    [No Abstract]   [Full Text] [Related]  

  • 20. CASE 12-2016 Ascending Aorta Dissection in a Jehovah's Witness Patient on Warfarin.
    Silvetti S; Crivellari M; Castiglioni A; Landoni G; Zangrillo A; Alfieri O; Koster A; Faraoni D; Bolliger D; Tanaka KA
    J Cardiothorac Vasc Anesth; 2016 Dec; 30(6):1709-1715. PubMed ID: 27639716
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.